Massachusetts Medical Society: Ethics Forum Speaker Bios

Ethics Forum Speaker Bios


2022 Interim Meeting Ethics Forum — The Ethical Implications of For-Profit Financing Models in Medical Practices and Institutions

Wednesday, November 30, 2022, 7:00 - 8:00 p.m. – Virtually via Zoom


Rebecca W. Brendel, MD, JD

Rebecca Weintraub Brendel, MD, JD

Dr. Brendel is Director of the Master of Bioethics Program and Associate Director of the Center for Bioethics at Harvard Medical School. She bases her clinical and forensic psychiatry practice at Massachusetts General Hospital, where she is Director of Law and Ethics at the Center for Law, Brain, and Behavior. She is Associate Professor of Psychiatry at Harvard Medical School. Dr. Brendel is also admitted to the Massachusetts Bar. She is past Medical Director of the One Fund Center for Boston Marathon bombing survivors at Massachusetts General Hospital and past Clinical Director of the Red Sox Foundation and Massachusetts General Hospital Home Base Program for returning veterans and their families.

Rebecca Weintraub Brendel, MD, JD, is President of the American Psychiatric Association (APA). Dr. Brendel is a Distinguished Fellow of the APA. Prior to assuming her position on the APA Board of Trustees, Dr. Brendel served as Chair of the APA Ethics Committee from 2019 to 2021. She has previously served as Parliamentarian to the APA Board of Trustees, Chair of the APA Ad Hoc Workgroup on Ethics (2014-2015), member of the APA-AMA Delegation, and Chair of the APA Bylaws Committee. She is a fellow and past president of the Academy of Consultation-Liaison Psychiatry (2018-2019), of which she served on the Board from 2010 to 2020. Dr. Brendel is incoming Chair of the Massachusetts Medical Society Committee on Ethics, Grievances, and Professional Standards and an appointed member of the American Medical Association Council on Ethical and Judicial Affairs (CEJA).

Dr. Brendel is a past Councilor and Ethics Committee Member of the Massachusetts Psychiatric Society. She has also served on the Massachusetts Bar Association Health Law Section Council and Mental Health Law Committee and in consultative roles to the Massachusetts Probate and Family Court, the One Fund Boston, and the Federation of State Medical Boards. Informed by her medical, legal, and ethics training and experience, Dr. Brendel writes, teaches, sits on journal editorial boards, and lectures nationally and internationally on critical topics at the intersection of psychiatry, ethics, human rights, and law.


Sachin H. Jain, MD, MBA, FACP

Sachin H. Jain, MD, MBA, FACP

Sachin (pronounced SUCH-in) H. Jain, MD, MBA is President and CEO of SCAN Group and Health Plan, where he is charged with leading the organization’s growth, diversification, and emerging efforts to reduce healthcare disparities. SCAN’s revenues top $4.3B and the organization serves more than 270,000 patients. Under Dr. Jain’s leadership SCAN has maintained its 4.5 STAR rating for the 5th year in a row; offered new products (ISNP) and expanded operations into Arizona and Nevada; launched new subsidiaries focused on home-based primary care, homeless healthcare, and PACE. Dr. Jain is also an adjunct professor of medicine at the Stanford University School of Medicine and a contributor at Forbes.

Previously, Dr. Jain was President and CEO of CareMore and Aspire Health, innovative care delivery systems with > $1.6B in revenues serving 200,000 Medicare and Medicaid patients and 2500 associates in 32 states. He led the diversification of CareMore, along with the acquisition and integration of Aspire Health. CareMore and Aspire now operate multiple innovative models of care including home-based primary care for frail and vulnerable patients; clinic and home-based models for acute and chronic disease management and prevention; home-based palliative care; and virtual care delivery. At CareMore, he pioneered and scaled the first clinical program in the world focused on social isolation.

Prior to joining CareMore, Dr. Jain was global Chief Medical Information & Innovation Officer at Merck & Co. He contemporaneously served as an attending physician at the Boston VA-Boston Medical Center and a member of faculties at Harvard Medical School and Harvard Business School. From 2009-2011, Dr. Jain worked in leadership roles at the US Department of Health and Human Services, where he was senior advisor to the administrator of the Centers for Medicare & Medicaid Services (CMS). Dr. Jain was the first acting deputy director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI). He also served as special assistant to the National Coordinator for Health Information Technology.

Dr. Jain is a respected thought leader in health care delivery. He is regularly recognized as a “Top 50 Most Influential Clinical Leader” and “100 Most Influential People in US Healthcare” by Modern Healthcare. Dr. Jain has also been recognized by the Boston VA Medical Center for excellence in clinical care provided to the veteran’s community with the “Golden Heart Award” and by Brigham and Women’s Hospital for excellence in mentorship. LinkedIn named him its top voice (#1) for healthcare.

Dr. Jain graduated magna cum laude from Harvard College with a BA in government and continued on to earn his MD from Harvard Medical School and MBA from Harvard Business School. He is a member of the boards of Cardiovascular Systems Inc (NASDAQ: CSII); Biofourmis; and the Make-A-Wish Foundation. He trained in medicine at the Brigham and Women's Medicine and Harvard Medical School, earned his board certification from the ABIM, and continues to practice medicine at the West Los Angeles VA Hospital. He is co-founder and co-editor-in-chief of the Elsevier journal Healthcare: The Journal of Delivery Science & Innovation and is an elected member of the National Academy of Social Insurance (NASI). He has published over 100 articles in journals such as the New England Journal, JAMA, Health Affairs, and the Harvard Business Review blogs and was an editor of the book, The Soul of a Doctor (Algonquin Press). He is an Aspen Institute Health Innovator’s Fellow and a Paul and Daisy Soros Fellow.


Jane M. Zhu, MD, MPP, MSHP

Jane M. Zhu, MD, MPP, MSHP

Jane M. Zhu, MD, MPP, MSHP, is an Assistant Professor of Medicine in the Division of General Internal Medicine at the Oregon Health & Science University. She holds a secondary appointment in Health Systems Management & Policy at the OHSU-PSU School of Public Health and is an adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania. Dr. Zhu's research centers on health care access and quality, particularly for mental/behavioral health services, as well as the effects of provider incentives and organization of care. Her work has been published in high-impact journals, including JAMA, NEJM, and Health Affairs, and has been cited in government and legislative reports.

Dr. Zhu also is a practicing primary care physician. She obtained her BSc degree in global health and international development from Duke University, where she was awarded a Fulbright fellowship. She received dual degrees in medicine and public policy from Harvard Medical School and Harvard's Kennedy School of Government. After internal medicine residency training at the University of California, San Francisco, she was selected as a National Clinician Scholar at the University of Pennsylvania where she completed a two-year fellowship.




Facebook logoTwitter logoLinkedInYouTube logoInstagram

Copyright © 2022. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | (781) 893-3800 | Member Information Hotline: (800) 322-2303 x7311